Advancing the scheduled time of hemodialysis is benificial for maintenance hemodialysis patients with gabapentin intolerance.
Liu
Jiung-Hsiun
JH
Yang
Yu-Wan
YW
Huang
Chiu-Ching
CC
D000368:Aged; D000588:Amines / Q000009:adverse effects*; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D018908:Muscle Weakness; D006435:Renal Dialysis; D013064:Speech Disorders; D014511:Uremia / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects*
D000588:Amines; D002121:Calcium Channel Blockers; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin